CH
BHVN icon

Canton Hathaway’s Biohaven BHVN Stock Holding History

Canton Hathaway’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336K Buy
22,600
+100
+0.4% +$1.08K 0.06% 102
2026
Q1 		$190K Hold
22,500
– – 0.04% 131
2025
Q4 		$254K Sell
22,500
-3,900
-15% -$48.3K 0.05% 122
2025
Q3 		$396K Sell
26,400
-4,100
-13% -$59.7K 0.08% 112
2025
Q2 		$430K Buy
30,500
+9,150
+43% +$163K 0.09% 104
2025
Q1 		$513K Hold
21,350
– – 0.1% 81
2024
Q4 		$797K Hold
21,350
– – 0.2% 51
2024
Q3 		$1.07M Sell
21,350
-500
-2% -$19.5K 0.27% 44
2024
Q2 		$758K Buy
21,850
+500
+2% +$19.8K 0.21% 51
2024
Q1 		$1.17M Hold
21,350
– – 0.31% 39
2023
Q4 		$914K Sell
21,350
-500
-2% -$15.6K 0.28% 41
2023
Q3 		$568K Buy
21,850
+500
+2% +$10.4K 0.18% 49
2023
Q2 		$511K Sell
21,350
-1,300
-6% -$22.4K 0.16% 56
2023
Q1 		$309K Buy
22,650
+5,050
+29% +$80.4K 0.11% 68
2022
Q4 		$244K Buy
17,600
+13,508
+330% +$191K 0.08% 82
2022
Q3 		$605K Buy
+4,092
New +$29.7K 0.22% 54

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Canton Hathaway's BHVN Position: Q2 2026 in Review

Canton Hathaway increased its Biohaven (BHVN) stake by 0.44% in Q2 2026, buying an estimated $1.08K and bringing the position to 22,600 shares worth $336K. The position accounts for 0.06% of the portfolio, ranked #102.

Canton Hathaway first reported a position in BHVN in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.17M in Q1 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Canton Hathaway held 22,600 shares of Biohaven worth $336K as of Q2 2026.
  • Canton Hathaway bought 100 Biohaven shares in Q2 2026, an estimated $1.08K.
  • Biohaven made up 0.06% of Canton Hathaway's portfolio in Q2 2026, its #102 holding.
  • Canton Hathaway first reported a position in Biohaven in Q3 2022 and has held it in 16 quarters since.
  • Canton Hathaway's Biohaven position peaked at $1.17M in Q1 2024.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.